Buclizine
Buclizine is an orally active antihistamine antiallergic compound. Buclizine is a potent teratogen in the rat and shows anti-tumor activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 82-95-1
- Formel: C28H33ClN2
- Molecular Weight:433.03
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle Histamine Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Buclizine (0.1-100 μM; 72 h) inhibits growth of MCF-7 cells[2].
Buclizine (9.625-77 μM; 72 h) arrests the cell cycle in the G1 phase in a dose-dependent manner[2].
Buclizine (0-75 μM; 72 h) decreases TCTP (translationally controlled tumor protein) and cell cycle regulatory proteins expression in MCF-7 cells, increases pro-apoptotic MCL-1S expression[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 cells
-
Concentration:0-100 μM
-
Incubation Time:72 hours
-
Result:Showed considerable growth inhibition (IC50=19.18 μM).
-
Cell Line:MCF-7 cells
-
Concentration:9.625, 19.25, 38.5, and 77 μM
-
Incubation Time:72 hours
-
Result:Increased the percentages of cells in the G1 phase to 73% at 77 μM.
-
Cell Line:MCF-7 cells
-
Concentration:0-75 μM
-
Incubation Time:72 hours
-
Result:Decreased TCTP expression by 40% at 75 μM.
Decreased cyclin D1, cyclin D3, CDK2 and CDK4 expression after 72 h.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Eighty-seven mature female rats weighing 240±20 grams[3]
-
Dosage:30, 40, 60, 100, and 200 mg/kg
-
Administration:30-200 mg/kg; tenth to fifteenth and twelfth to fifteenth days of gestation
-
Result:Resulted in malformations in 100% of the young at a dose level of 60-100 mg/kg.
Chemical Information
-
CAS. Nr. 82-95-1
-
Molecular Weight 433.03
-
Formel C28H33ClN2
-
SMILES
CC(C1=CC=C(CN2CCN(C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4)CC2)C=C1)(C)C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Gamal A E Mostafa, et al. Buclizine. Profiles Drug Subst Excip Relat Methodol. 2011;36:1-33. [Content Brief]
[2]. Ean-Jeong Seo, et al. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy. Oncotarget. 2016 Mar 29;7(13):16818-39. [Content Brief]
[3]. C T King, et al. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol. 1966 May 1;95(1):109-11. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Buclizine Related Classifications
HY-A0128 Related Classifications
Powered by Bioz